Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Nicorandil

An anti-anginal drug with a dual mechanism: it acts as a nitrate and also opens ATP-sensitive potassium channels, widening the blood vessels. Created in Japan, patented in 1976 and approved in 1983, it is used for angina pectoris. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.

Did you know?Its name reveals its structure: it is a derivative of nicotinamide, a form of vitamin B3, with a nitrate group attached.

NicorandilGo to the active ingredient →
NicorandilActive ingredientNicorandilCat. No. P-N049-001CAS 65141-46-0
Nicorandil-d4Isotopically labelledNicorandil-d4Cat. No. P-N049-008CAS 1132681-23-2

EDQM standards 2

The official European Pharmacopoeia standards for this family.

Reference substanceNicorandil CRSEDQM code Y0001761Family Nicorandil

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.